ALCC News

After a record breaking number of deals last week, the IPO market cooled off for the shortened holiday week, with just two micro-cap IPOs raising $45 million.  Preclinical RNA biotech Transcode Therapeutics (RNAZ) priced at $4 to raise $25 million at a $54 million market cap. This oncology biotech develops RNA therapeutics for the treatment of solid...read more

AltC Acquisition, a blank check company formed by Michael Klein and OpenAI co-founder Sam Altman, raised $450 million by offering 45 million shares at $10. The company had previously filed to offer 40 million shares at the same price. The offering did not contain units with warrants attached. The upsized deal raised 13% more in proceeds than previously anticipated.  The...read more

AltC Acquisition, a blank check company formed by Michael Klein and OpenAI co-founder Sam Altman, lowered the proposed deal size for its upcoming IPO on Friday. The New York, NY-based company now plans to raise $400 million by offering 40 million shares at $10. The company had previously filed to offer 100 million units at the same price. The company is now offering shares only...read more